Rankings
▼
Calendar
ESPR FY 1999 Earnings — Esperion Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ESPR
Esperion Therapeutics, Inc.
$488M
FY 1999 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$0
Gross Profit
-$683,223
Operating Income
-$12M
Net Income
-$11M
EPS (Diluted)
$-7.94
Cash Flow
Operating Cash Flow
-$8M
Free Cash Flow
-$9M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$8M
Total Liabilities
$5M
Stockholders' Equity
$3M
Cash & Equivalents
$6M
← FY 2000
All Quarters
